,
Koivula, Robert W. https://orcid.org/0000-0002-1646-4163
Forgie, Ian M.
Kurbasic, Azra
Viñuela, Ana
Heggie, Alison
Giordano, Giuseppe N.
Hansen, Tue H.
Hudson, Michelle
Koopman, Anitra D. M.
Rutters, Femke
Siloaho, Maritta
Allin, Kristine H.
Brage, Søren
Brorsson, Caroline A.
Dawed, Adem Y.
De Masi, Federico
Groves, Christopher J.
Kokkola, Tarja
Mahajan, Anubha
Perry, Mandy H.
Rauh, Simone P.
Ridderstråle, Martin
Teare, Harriet J. A.
Thomas, E. Louise
Tura, Andrea
Vestergaard, Henrik
White, Tom
Adamski, Jerzy
Bell, Jimmy D.
Beulens, Joline W.
Brunak, Søren
Dermitzakis, Emmanouil T.
Froguel, Philippe
Frost, Gary
Gupta, Ramneek
Hansen, Torben
Hattersley, Andrew
Jablonka, Bernd
Kaye, Jane
Laakso, Markku
McDonald, Timothy J.
Pedersen, Oluf
Schwenk, Jochen M.
Pavo, Imre
Mari, Andrea
McCarthy, Mark I.
Ruetten, Hartmut
Walker, Mark
Pearson, Ewan https://orcid.org/0000-0001-9237-8585
Franks, Paul W. https://orcid.org/0000-0002-0520-7604
Funding for this research was provided by:
Innovative Medicines Initiative Joint Undertaking (IMI-DIRECT n°115317)
Novo Nordisk (STAR Award co-financed PhD fellowship (R.K.))
European Research Council (ERC-2015-CoG_NASCENT_681742 (P.W.F.))
Wellcome Trust (Investigator award 102820/Z/13/Z (E.R.P))
Novo Nordisk Foundation (NNF17OC0027594 (S.Bru.))
Article History
Received: 13 July 2018
Accepted: 10 April 2019
First Online: 15 June 2019
Duality of interest
: The authors declare that there is no duality of interest associated with this manuscript.